AIDP granted US patents for cognitive health supplement17 August 2012Functional ingredients distributor AIDP has secured US patents for its cognitive and neurological health magnesium composition Magtein. The patents, titled "Magnesium compositions and uses thereof for cognitive function" (Patent 8,178,118) and "Magnesium compositions and uses thereof for neurological disorders" (Patent 8,142,803), protect Magtein's magnesium compositions and its use for any magnesium L-threonate-containing food, nutritional supplements and drugs for enhancing cognitive function or ameliorating the effects of a neurological disorder. Such products are designed for those suffering from loss of cognitive function, loss of memory, Alzheimer's disease, depression, attention deficit hyperactivity disorder, Amyotrophic lateral sclerosis (ALS), Parkinson's disease, migraine, anxiety disorder and mood disorder. "We truly believe that Magtein is a game changing ingredient that will benefit millions of busy and stressed consumers by helping to improve their quality of life," said Edward Lee, AIDP’s president. "AIDP, as the exclusive provider of all Magtein magnesium L-threonate, is uniquely positioned to serve the functional food and beverage marketplace to support the cognitive health category." AIDP said that research on Magtein, which was discovered by scientists at Massachusetts Institute of Technology (MIT), and Tsinghua University in Beijing, China, has shown the supplement to significantly increase brain magnesium levels. Animal research has concluded that it could improve short-term and long-term memory as well as spatial recognition. | |
 Exhibitions Fi Europe | Hi/Ni China | Fi India | Fi Asia | Fi South America | Health ingredients Europe, Ni & NuW | Fi Istanbul Languages      
| |
